Stay updated on ZYN002 Long-Term Safety in Children with FXS Clinical Trial
Sign up to get notified when there's something new on the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page.

Latest updates to the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been changed from June 2025 to July 2025.SummaryDifference1%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.2.SummaryDifference2%
- Check43 days agoChange DetectedThe page has removed a reference to an erratum related to a publication on therapies for Angelman syndrome.SummaryDifference0.4%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check79 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about the ZYN002 study and its administration for Fragile X Syndrome, while introducing a new revision number and the term 'Open-Label'.SummaryDifference31%
Stay in the know with updates to ZYN002 Long-Term Safety in Children with FXS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page.